I didn’t know EF Hutton was still around. I am looking for larger increases than 70%. I still think for all solid tumors you have stock in the hundreds. If each patient uses 8 doses just in Sawston they have storage for 375,000 patients.
(375,000 X $100,000) / 1.7 Billion shares, if it comes to that = $22
I will say 50% margins and I think that is extremely conservative leaving $11 in eps.
Tack on whatever multiple you want to the eps and I will use 20 leads to $220 share price just for Sawston capacity. Of course DCVax has to become an integral part of SOC for solid tumors. I think the odds are pretty good. And that doesn’t include DC Vax Direct.
I am sure EF Hutton has a better idea of the other companies plans and operational $ than what we know here. Everyday we guess.